Dyslipidemia, Diabetes and Atherosclerosis: Role of Inflammation and ROS-Redox-Sensitive Factors
The prevalence of diabetes is growing at an alarming rate with increased disability, morbidity, and often premature mortality because of the various complications of this disorder. Chronic hyperglycemia, dyslipidemia, and other metabolic alterations lead to the development and progression of macro-...
Guardado en:
Autores principales: | Elham Hasheminasabgorji, Jay C. Jha |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d5bf0b39bcbc43c7979cd8078e26cf61 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
NLRP3 inflammasome promotes diabetes-induced endothelial inflammation and atherosclerosis
por: Wan Z, et al.
Publicado: (2019) -
Progress of research on dyslipidemia accompanied by nephrotic syndrome
por: Min Tao, et al.
Publicado: (2020) -
The role of endothelial damage and dyslipidemia in the development of cardiovascular pathology in psoriatic arthritis
por: Zarema R. Khismatullina, et al.
Publicado: (2021) -
Vaccine targeting ANGPTL3 ameliorates dyslipidemia and associated diseases in mouse models of obese dyslipidemia and familial hypercholesterolemia
por: Hirotaka Fukami, et al.
Publicado: (2021) -
Current Practices and Gaps in Management of Dyslipidemia in Type 2 Diabetes Mellitus (T2DM) in Accordance with American Diabetes Association (ADA) Guidelines: A Subset Analysis from a Real-World, Cross-Sectional Observational Study (LEADD Study)
por: Das AK, et al.
Publicado: (2021)